Evaluating the Streck ARM-D® Kit for Detecting β-Lactamase Genes
Author Information
Author(s): Yoo Brian B., Yamamoto Norihisa, Quintero Justina Ilutsik, Machado Maria Jose, Sabour Sarah, Blosser Sara, Karlsson Maria, Rasheed James Kamile, Brown Allison C.
Primary Institution: Centers for Disease Control and Prevention
Hypothesis
The study aims to evaluate the performance of the ARM-D® Kit, β-lactamase for molecular detection of acquired β-lactamase genes.
Conclusion
The ARM-D® Kit, β-lactamase detected a wide range of β-lactamase genotypes at a low upfront cost.
Supporting Evidence
- The Streck assay demonstrated 100% sensitivity and 99.9% specificity in detecting β-lactamase genes.
- The study included a diverse collection of 113 Gram-negative isolates.
- The ARM-D® Kit is cost-effective compared to other commercially available PCR kits.
Takeaway
The Streck ARM-D® Kit is a tool that helps find specific germs that can resist certain antibiotics, making it easier for doctors to treat infections.
Methodology
The study used a multiplex PCR assay to evaluate 113 Gram-negative isolates for the detection of β-lactamase genes.
Potential Biases
The study was funded by Streck, which provided the kits but had no control over the analysis.
Limitations
The evaluation only covered 164 out of 473 gene variants specified in the kit brochure, and the assay was not designed for direct detection in clinical samples.
Participant Demographics
The isolates included a diverse collection of Gram-negative bacteria from the CDC & FDA Antimicrobial Resistance Isolate Bank.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website